So anyone with a few postnominals after their name is immune...

First 36 Last

Share
Profile

Follow
Mossberg

1,407 Posts.

249

26/11/18

19:21

Post #: 36644903
Share

Originally posted by Dr.Who ↑

And what qualifications do you hold Jim to call people such as James Shipton braindead?

You make yourself look silly and irrelevant!

James Shipton BA (Melbourne), LLB (Hons) (Monash)

James Shipton commenced as ASIC Chair on 1 February 2018.
James has more than 20 years experience in regulation, financial markets, the law and academia – internationally and in Australia.
Most recently, he was the Executive Director of Harvard Law School's Program on International Financial Systems. Prior to that, James was an Executive Director and Commission member of the Securities and Futures Commission (SFC) of Hong Kong, where he led the Intermediaries (Supervision & Licensing) Division.
Before the SFC, James spent almost a decade at Goldman Sachs in Hong Kong in senior roles as a Managing Director in both the securities division and the Asia Pacific executive office. Prior to that, he ran the hedge fund consultancy business of Eurekahedge, co-founded ComplianceAsia (Asia’s first pan-regional independent regulatory consulting firm) in Singapore and worked in equity capital markets at Dresdner Kleinwort Wasserstein (now Commerzbank) in Hong Kong and London.
James began his career as a funds and securities lawyer at law firms Linklaters and Blake Dawson Waldron in Melbourne, Hong Kong and Bangkok.
James has previously served as Deputy Chair of the Alternative Investment Management Association’s Hong Kong & China Chapter, Vice Chair of the Asian Securities Industry and Financial Markets Association and a Board Member of the Hong Kong Treasury Markets Association. He has also served on the Professional Advisory Board for the Asian Institute of International Financial Law, the Hong Kong Advisory Group for the Fred Hollows Foundation and the business advisory councils to the United Nations Economics and Social Commission for Asia Pacific (UNESCAP) and the Hong Kong Securities and Investment Institute.

Expand

So anyone with a few postnominals after their name is immune from criticism?

That’s lazy and fallacious thinking imo. Perhaps you left formal education at a young age and are awe-struck by ‘book smart’ people with a tertiary education

Tip from me to you: you do yourself no favours putting yourself down like that. Every man should be judged by the quality of his ideas and consequences of his actions

Last edited by Mossberg: 26/11/18

SGH Price at posting: $2.48 Sentiment: None Disclosure: Not Held
4 Upvote

1 Great analysis

Reply

Top Stories

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

HotCopper Highlights: Your most watched stocks for Week 47, 2024

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

There are more pages in this discussion • 25 more messages in this thread...

First 36 Last

Add SGH (ASX) to my watchlist

So anyone with a few postnominals after their name is immune...

Top Stories

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

Sales growth pushes Lovisa's fortunes (and shares) upwards

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Featured News